Zapata Quantum, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
ZPTA$1.03-1.9%Stored close · as of Jul 8, 2026
Contents
Condensed Consolidated Balance Sheets – As of March 31, 2026 (Unaudited) and December 31, 2025
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets · (Unaudited) | ||
| Current assets: | ||
| Cash | $642 | $1,659 |
| Prepaid expenses and other current assets | 158 | 181 |
| Total current assets | 800 | 1,840 |
| Other non-current assets | 404 | 432 |
| Total assets | $1,204 | $2,272 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $4,070 | $3,963 |
| Accrued expenses and other current liabilities | 1,547 | 1,764 |
| Other liabilities | 406 | 406 |
| Convertible promissory notes, current ($300 to related parties) | 3,227 | 3,133 |
| Senior secured notes, current | 1,311 | 1,273 |
| Total liabilities | 10,561 | 10,539 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ deficit | ||
| Convertible preferred stock (Series A), $0.0001 par value; 15,000 shares authorized; 15,000 and 15,000 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Convertible preferred stock (Series C), $0.0001 par value; 23,000 shares authorized; 11,983 and 11,983 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common Stock, $0.0001 par value; 600,000,000 shares authorized; 172,318,506 and 172,318,506 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 17 | 17 |
| Additional paid-in capital | 110,449 | 110,211 |
| Accumulated other comprehensive loss | (180) | (162) |
| Accumulated deficit | (119,643) | (118,333) |
| Total stockholders’ deficit | (9,357) | (8,267) |
| Total liabilities and stockholders’ deficit | $1,204 | $2,272 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue | $— | $— |
| Cost of revenue | — | — |
| Gross profit | — | — |
| Operating expenses: | ||
| Sales and marketing | 173 | — |
| Research and development | 235 | — |
| General and administrative | 789 | 680 |
| Total operating expenses | 1,197 | 680 |
| Loss from operations | (1,197) | (680) |
| Other income (expense): | ||
| Interest expense | (132) | (102) |
| Other income (expense), net | 19 | 12 |
| Total other expense, net | (113) | (90) |
| Net loss before income taxes | (1,310) | (770) |
| Provision for income taxes | — | — |
| Net loss | $(1,310) | $(770) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.01) | $(0.02) |
| Weighted-average common shares outstanding, basic and diluted | 172,318,506 | 42,482,376 |
| Net loss | $(1,310) | $(770) |
| Foreign currency translation adjustment | (18) | (14) |
| Comprehensive loss | $(1,328) | $(784) |
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
For the three months ended March 31, 2026 and 2025
(In thousands, except share amounts)
| Convertible Preferred Stock ($0.0001 par value) · Common Stock ($0.0001 par value) · Additional Paid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Loss | Deficit | Deficit | |
| Balances at December 31, 2025 | 26,983 | $— | 172,318,506 | $17 | $110,211 | $(162) | $(118,333) | $(8,267) |
| Stock-based compensation expense | — | — | — | — | 238 | — | — | 238 |
| Net loss | — | — | — | — | — | — | (1,310) | (1,310) |
| Cumulative translation adjustment | — | — | — | — | — | (18) | — | (18) |
| Balances at March 31, 2026 | 26,983 | $— | 172,318,506 | $17 | $110,449 | $(180) | $(119,643) | $(9,357) |
| Convertible Preferred Stock ($0.0001 par value) · Common Stock ($0.0001 par value) · Additional Paid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Loss | Deficit | Deficit | |
| Balances at December 31, 2024 | — | $— | 43,589,506 | $4 | $104,301 | $(109) | $(127,669) | $(23,473) |
| Vesting of restricted stock units | — | — | 25,000 | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | 44 | — | — | 44 |
| Net loss | — | — | — | — | — | — | (770) | (770) |
| Cumulative translation adjustment | — | — | — | — | — | (14) | — | (14) |
| Balances at March 31, 2025 | — | $— | 43,614,506 | $4 | $104,345 | $(123) | $(128,439) | $(24,213) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.